A young woman treated for suspected methaemoglobinaemia instead experiences worsening haemolysis that reveals a previously ...

The new Non-UPF Verified Standard, developed by The Non-GMO Project, draws a clear line between necessary innovation and needless manipulation. It helps the food industry design for shelf stability ...

Fermenta Biotech Limited (BSE: 506414) (Bloomberg: FERMENTA.IN) (Reuters: FERM.BO), India's leading manufacturer of ...

As of Wednesday, December 24, Agios Pharmaceuticals, Inc.’s AGIO share price has surged by 16.31%, which has investors questioning if this is right time to sell.

Important Safety Information Indication Elfabrio ® (pegunigalsidase alfa for injection) is an enzyme replacement therapy indicated for the longterm treatment of adult patients with a confirmed ...

Scientists identify measurable cellular changes that flag higher cancer risk more than a decade before tumors appear. In A ...

Elfabrio (R) (pegunigalsidase alfa for injection) is an enzyme replacement therapy indicated for the longterm treatment of adult patients with a confirmed diagnosis of Fabry disease (deficiency of ...

The first infant to undergo gene-editing therapy has accomplished another first — his first steps. KJ Muldoon is walking and ...

Eustachian tube dysfunction often determines whether a routine ear infection clears quickly or develops into a persistent ...

BioMarin Pharmaceutical’s strong rare disease drug portfolio and Amicus acquisition drive a ‘Buy’ rating. Click here to read my latest analysis of BMRN stock.

Amid news of the splashy $4.8 billion Amicus buy, BioMarin has slipped in the discontinuation of a genetic liver disease ...

LMNT reports that hangovers stem from acetaldehyde, dehydration, and electrolyte imbalances; stay hydrated and drink ...